1-20 of 67
combined modality therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Mikhail Kosiborod, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S158–S190
https://doi.org/10.2337/dc23-S010
Published: 12 December 2022
View article titled, 10. Cardiovascular Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em>
Open the PDF for 10. Cardiovascular Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em> in another window
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee
Journal: Diabetes Care
Diabetes Care 2022;45(Supplement_1):S144–S174
https://doi.org/10.2337/dc22-S010
Published: 16 December 2021
View article titled, 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2022</em>
Open the PDF for 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2022</em> in another window
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2021;44(Supplement_1):S125–S150
https://doi.org/10.2337/dc21-S010
Published: 04 December 2020
View article titled, 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2021</em>
Open the PDF for 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2021</em> in another window
Journal Articles

Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

Muhammad Abdul-Ghani, Curtiss Puckett, John Adams, Ahmad Khattab, Gozde Baskoy, Eugenio Cersosimo, Curtis Triplitt, Ralph A. DeFronzo
Journal: Diabetes Care
Diabetes Care 2021;44(2):433–439
https://doi.org/10.2337/dc20-0978
Published: 03 December 2020
View article titled, Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Open the PDF for Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT in another window
Journal Articles

In This Issue of Diabetes Care

Journal: Diabetes Care
Diabetes Care 2020;43(6):1167–1168
https://doi.org/10.2337/dc20-ti06
Published: 12 May 2020
View article titled, In This Issue of <em>Diabetes Care</em>
Open the PDF for In This Issue of <em>Diabetes Care</em> in another window
Journal Articles

Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey

Phuc Le, Alexander Chaitoff, Anita D. Misra-Hebert, Wen Ye, William H. Herman, Michael B. Rothberg
Journal: Diabetes Care
Diabetes Care 2020;43(6):1227–1233
https://doi.org/10.2337/dc19-2424
Published: 31 March 2020
View article titled, Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey
Open the PDF for Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey in another window
Includes: Supplementary data
Journal Articles

Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes

Ali Muhammed Ali, Robert Martinez, Hussein Al-Jobori, John Adams, Curtis Triplitt, Ralph DeFronzo, Eugenio Cersosimo, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2020;43(6):1234–1241
https://doi.org/10.2337/dc18-2460
Published: 27 March 2020
View article titled, Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA<sub>1c</sub>, in Patients With Type 2 Diabetes
Open the PDF for Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA<sub>1c</sub>, in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2020;43(Supplement_1):S111–S134
https://doi.org/10.2337/dc20-S010
Published: 16 December 2019
View article titled, 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2020</em>
Open the PDF for 10. Cardiovascular Disease and Risk Management: <em>Standards of Medical Care in Diabetes—2020</em> in another window
Journal Articles

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556

Michaël J.B. van Baar, Charlotte C. van Ruiten, Marcel H.A. Muskiet, Liselotte van Bloemendaal, Richard G. IJzerman, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2019;42(10):2015
https://doi.org/10.2337/dc19-er10a
Published: 20 August 2019
View article titled, Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556
Open the PDF for Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556 in another window
Journal Articles

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Fernando Bril, Diane M. Biernacki, Srilaxmi Kalavalapalli, Romina Lomonaco, Sreevidya K. Subbarayan, Jinping Lai, Fermin Tio, Amitabh Suman, Beverly K. Orsak, Joan Hecht, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2019;42(8):1481–1488
https://doi.org/10.2337/dc19-0167
Published: 21 May 2019
View article titled, Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Open the PDF for Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Index

Journal: Diabetes Care
Diabetes Care 2019;42(Supplement_1):S187–S193
https://doi.org/10.2337/dc19-in01
Published: 07 December 2018
View article titled, Index
Open the PDF for Index in another window
Journal Articles

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

Michaël J.B. van Baar, Charlotte C. van Ruiten, Marcel H.A. Muskiet, Liselotte van Bloemendaal, Richard G. IJzerman, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2018;41(8):1543–1556
https://doi.org/10.2337/dc18-0588
Published: 11 July 2018
View article titled, SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
Open the PDF for SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management in another window
Journal Articles

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40: 325–331

Muhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis Triplitt, Ralph A. DeFronzo, Mahmoud Zirie, Amin Jayyousi
Journal: Diabetes Care
Diabetes Care 2017;40(8):1134
https://doi.org/10.2337/dc17-er08d
Published: 14 June 2017
View article titled, Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40: 325–331
Open the PDF for Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40: 325–331 in another window
Journal Articles

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2017;40(4):614–624
https://doi.org/10.2337/dc16-1957
Published: 10 March 2017
View article titled, Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Open the PDF for Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials in another window
Includes: Supplementary data
Journal Articles

Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study

Muhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis Triplitt, Ralph A. DeFronzo, Mahmoud Zirie, Amin Jayyousi
Journal: Diabetes Care
Diabetes Care 2017;40(3):325–331
https://doi.org/10.2337/dc16-1738
Published: 17 January 2017
View article titled, Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
Open the PDF for Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study in another window
Includes: Supplementary data
Journal Articles

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

Avivit Cahn, William T. Cefalu
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S137–S145
https://doi.org/10.2337/dcS15-3007
Published: 16 July 2016
View article titled, Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
Open the PDF for Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes in another window
Journal Articles

Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes

Julio Rosenstock, Leonard Chuck, Manuel González-Ortiz, Kate Merton, Jagriti Craig, George Capuano, Rong Qiu
Journal: Diabetes Care
Diabetes Care 2016;39(3):353–362
https://doi.org/10.2337/dc15-1736
Published: 19 January 2016
View article titled, Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes
Open the PDF for Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?

Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2015;38(3):373–375
https://doi.org/10.2337/dc14-2517
Published: 12 February 2015
View article titled, Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?
Open the PDF for Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes? in another window
Journal Articles

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. Diabetes Care 2013;36: 4022–4029

Priscilla Hollander, Alok K. Gupta, Raymond Plodkowski, Frank Greenway, Harold Bays, Colleen Burns, Preston Klassen, Ken Fujioka, for the COR-Diabetes Study Group
Journal: Diabetes Care
Diabetes Care 2014;37(2):587
https://doi.org/10.2337/dc14-er02
Published: 11 January 2014
View article titled, Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. Diabetes Care 2013;36: 4022–4029
Open the PDF for Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. Diabetes Care 2013;36: 4022–4029 in another window
Journal Articles

Summary of Revisions to the 2014 Clinical Practice Recommendations

Journal: Diabetes Care
Diabetes Care 2014;37(Supplement_1):S4
https://doi.org/10.2337/dc14-S004
Published: 16 December 2013
View article titled, Summary of Revisions to the 2014 Clinical Practice Recommendations
Open the PDF for Summary of Revisions to the 2014 Clinical Practice Recommendations in another window